37.23
price down icon0.11%   -0.035
 
loading
Schlusskurs vom Vortag:
$37.27
Offen:
$37.1
24-Stunden-Volumen:
1.33M
Relative Volume:
0.35
Marktkapitalisierung:
$15.70B
Einnahmen:
$2.26B
Nettoeinkommen (Verlust:
$1.09B
KGV:
15.89
EPS:
2.3431
Netto-Cashflow:
$2.70B
1W Leistung:
+3.39%
1M Leistung:
+3.33%
6M Leistung:
+17.85%
1J Leistung:
+30.45%
1-Tages-Spanne:
Value
$36.84
$37.50
1-Wochen-Bereich:
Value
$36.00
$37.56
52-Wochen-Spanne:
Value
$24.05
$37.56

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
Firmenname
Royalty Pharma Plc
Name
Telefon
(212) 883-0200
Name
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Name
Mitarbeiter
99
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-11
Name
Neueste SEC-Einreichungen
Name
RPRX's Discussions on Twitter

Vergleichen Sie RPRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RPRX
Royalty Pharma Plc
37.25 15.62B 2.26B 1.09B 2.70B 2.3431
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.96 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.42 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
342.46 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
604.83 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.86 31.87B 3.81B -644.79M -669.77M -6.24

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-16 Eingeleitet Morgan Stanley Overweight
2024-06-03 Herabstufung UBS Buy → Neutral
2022-06-14 Fortgesetzt UBS Buy
2022-05-13 Eingeleitet Scotiabank Sector Outperform
2022-04-27 Eingeleitet Goldman Buy
2022-04-14 Hochstufung JP Morgan Neutral → Overweight
2022-04-06 Fortgesetzt Morgan Stanley Overweight
2021-10-29 Hochstufung Citigroup Neutral → Buy
2021-07-30 Eingeleitet Tigress Financial Buy
2020-11-09 Hochstufung UBS Neutral → Buy
2020-07-14 Eingeleitet Evercore ISI In-line
2020-07-13 Eingeleitet BofA Securities Buy
2020-07-13 Eingeleitet Citigroup Neutral
2020-07-13 Eingeleitet Cowen Outperform
2020-07-13 Eingeleitet Goldman Neutral
2020-07-13 Eingeleitet JP Morgan Neutral
2020-07-13 Eingeleitet Morgan Stanley Equal-Weight
2020-07-13 Eingeleitet SunTrust Buy
2020-07-13 Eingeleitet UBS Neutral
Alle ansehen

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

pulisher
10:00 AM

Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

10:00 AM
pulisher
06:30 AM

Pacific Capital Partners Ltd Takes Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

06:30 AM
pulisher
03:34 AM

Envestnet Asset Management Inc. Boosts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

03:34 AM
pulisher
Jul 29, 2025

Royalty Pharma plc stock volume spike explainedScalable Portfolio Growth Suggestions Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 22:21:39 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Baillie Gifford & Co. Decreases Stake in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Machine Learning Models Forecast Royalty Pharma plc UptickConsistent Income Focused Trade List Analyzed - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Can Royalty Pharma plc Regain Momentum After BreakdownCommunity Shared Smart Money Signals Show Movement - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Bollinger Bands Expand on Royalty Pharma plc — Volatility AheadWeekly Chart Analysis With Entry Advice Provided - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Royalty Pharma stock hits 52-week high at 36.89 USD - Investing.com Australia

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Royalty Pharma plc stock attracting strong analyst attentionExceptional stock performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Royalty Pharma plc stockSuperior portfolio returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Ridgewood Investments LLC Decreases Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Royalty Pharma plc stock price move sharplyInvest confidently with real-time updates - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Mediolanum International Funds Ltd Lowers Stake in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Position Trimmed by Allianz Asset Management GmbH - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Cwm LLC Increases Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

What is Royalty Pharma plc company’s growth strategyUnmatched profit growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Royalty Pharma plc compare to its industry peersCapitalize on strong market momentum - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Royalty Pharma plc stock overvalued or undervaluedUnlock powerful trading signals and alerts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 08:51:02 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Royalty Pharma plcMaximize your portfolio’s earning potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Royalty Pharma plc stock expected to show significant growthDynamic profit opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What markets is GCLWW expanding into Is Royalty Pharma plc stock a good long term investment optionGet daily updates on promising stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Vestor Capital LLC Takes $12.60 Million Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 27, 2025
pulisher
Jul 26, 2025

Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month HighHere's What Happened - MarketBeat

Jul 26, 2025
pulisher
Jul 26, 2025

Royalty Pharma: A High-Margin, Earnings-Driven Opportunity in the Biopharma Royalty Space - AInvest

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Royalty Pharma plc stockFree Wealth Planning Blueprint - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Royalty Pharma plc Stock Analysis and ForecastSuperior portfolio returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Royalty Pharma plc a good long term investmentDouble-digit growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Royalty Pharma (NASDAQ:RPRX) Given New $42.00 Price Target at Citigroup - MarketBeat

Jul 25, 2025
pulisher
Jul 24, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Holdings Lifted by Los Angeles Capital Management LLC - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by New York State Common Retirement Fund - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Royalty Pharma Plc's (NASDAQ:RPRX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Winners And Losers Of Q1: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Edgestream Partners L.P. Makes New $659,000 Investment in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Royalty Pharma plc stock pricePhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Citigroup maintains Buy rating, raises PT for Royalty Pharma to $42. - AInvest

Jul 22, 2025

Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.74
price up icon 0.61%
$106.69
price up icon 1.63%
$26.90
price up icon 0.82%
$110.35
price down icon 0.88%
biotechnology ONC
$299.86
price down icon 1.92%
Kapitalisierung:     |  Volumen (24h):